BioProduction by Sekisui offers contract development and manufacturing services tailored for the biopharmaceutical industry. With a facility in the UK that boasts over 40 years of large scale fermentation and purification experience, Sekisui demonstrates expertise in the scale-up and manufacturing of enzymes, plasmids, and other proteins essential for the production of biopharmaceuticals. Specialising as a biologics CDMO, the company focuses on microbial fermentation and purification. Currently, they are undergoing a $19M expansion of their cGMP facility for drug substance manufacturing, which is set to be completed in 2024.

Services include:
- Process Development
- Bioprocessing
- Contract Manufacturing (CMO)
- Manufacturing
- Downstream Processing
- Fermentation
- Lyophilization
- APIs (Active Pharmaceutical Ingredients)
- Biologics
- Microbial-based Therapeutic Proteins
- Proteins
- Microbial Fermentation
- Protein Extraction/Purification
- Raw Materials
- Technology Transfer
- Contract Development and Manufacturing (CDMO)

Sekisui is committed to providing comprehensive solutions in the biopharmaceutical sector, ensuring high-quality manufacturing and development services to meet industry demands. For further information, please visit bioproduction-sekisui.com.